1 min read
Add as a preferred source on GoogleAnnovis Bio Receives NYSE Noncompliance Notice Over Listing Shortfalls
The notice cited a 30-trading-day average market capitalization of about $48.4 million and a stockholders’ deficit of about $4.3 million.
Annovis Bio, Inc. (NYSE: ANVS) received a noncompliance notice from the New York Stock Exchange on Oct. 29 after falling short of continued-listing standards for market capitalization and stockholders’ equity.
The company’s average market capitalization over 30 trading days was about $48.4 million as of Oct. 28. Its stockholders’ deficit was about $4.3 million as of June 30.
Riza Dagoc
Riza Dagoc reports on regulation, investing and the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.